Results 191 to 200 of about 3,076,940 (300)

Epidemiology and health burden of infective endocarditis: a comparative analysis of Australian vs global trends from 1990 to 2021

Internal Medicine Journal, EarlyView.
Abstract Background Infective endocarditis (IE) is an uncommon but life‐threatening disease with evolving patient risk profiles and management strategies. However, its impact on the Australian healthcare system has not been described. Aims To quantify the healthcare burden of IE in Australia over time in the past three decades and compare outcomes with
David M. Chye, Kate L. Drummond, Thalys Sampaio Rodrigues, Elizabeth Paratz, Robert Horvath, Eugene Athan, Louise M. Burrell, Natasha E. Holmes, Olivia C. Smibert, Anoop N. Koshy   +9 more
wiley   +1 more source

Trajectory of macrotroponin in a community cohort

Internal Medicine Journal, EarlyView.
Abstract Background Cardiac troponin I (cTnI) is a biomarker for myocardial injury. However, macrotroponin, a complex of cTnI and endogenous cardiac troponin autoantibodies, may artefactually elevate cTnI levels with potential to mislead clinicians, leading to inappropriate investigation and management.
Duncan J. Campbell, Fei Fei Gong, Michele McGrady, David L. Prior, Christopher M. Reid, Christina M. Trambas   +5 more
wiley   +1 more source

Left ventricular thrombus in Takotsubo syndrome and ST-elevation myocardial infarction. [PDF]

Open Heart
Jha S, Simonsson M, Poller A, Molander L, Thorleifsson S, Pirazzi C, Bentzel S, Torild P, Andersson EA, Shekka Espinosa A, Sevastianova V, Salahuddin S, Zeijlon R, Elmahdy A, Skoglund K, Omerovic E, Redfors B.   +16 more
europepmc   +1 more source

Semaglutide in type 2 diabetes and chronic kidney disease in Australia: practical clinical considerations from a multidisciplinary panel

Internal Medicine Journal, EarlyView.
Abstract Chronic kidney disease (CKD) and cardiovascular disease (CVD) are major causes of morbidity and mortality in people with type 2 diabetes (T2D). Contemporary CKD guidelines increasingly support incorporation of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) as an additional pillar of cardiorenal therapy alongside renin–angiotensin ...
Eugenia Pedagogos, Roger Chen, Adam Nelson, Sunil Badve, Roy Rasalam, Richard MacIsaac   +5 more
wiley   +1 more source

Predictors of a prolonged puncture-wire time in patients with ST-Elevation Myocardial Infarction (STEMI). [PDF]

BMC Cardiovasc Disord
Günes-Altan M, Achenbach S, Altstidl JM, Moshage M, Strupp H, Lorenz L, Scholl S, Marwan M, Troebs M, Gaede L.   +9 more
europepmc   +1 more source

Extracellular Traps in Coronary Thrombus Aspirates from Patients with ST-Elevation Myocardial Infarction. [PDF]

Int J Mol Sci
Pangonytė D, Šimonytė S, Lesauskaitė V, Siratavičiūtė V, Bakšytė G, Marcinkevičienė J, Stanionienė Z, Utkienė L, Jusienė L, Radikė R, Jaruševičius G, Unikas R, Vitkauskienė A, Dobilienė O.   +13 more
europepmc   +1 more source

Androgen-Modulating Drugs and Severe Complications After ST-Elevation Myocardial Infarction.

JAMA Netw Open
Colldén H, Lundberg CE, Björck L, Redfors B, Rosengren A, Tivesten Å.   +5 more
europepmc   +1 more source

Difficulty in identifying the culprit lesion in ST-elevation myocardial infarction with marked coronary tortuosity. [PDF]

J Cardiol Cases
Yamanaka T, Tomimitsu Y, Mabuchi K, Fukunaga H, Ichinohe Y, Higashitani M.   +5 more
europepmc   +1 more source

Cardiac structure and function in psoriasis: A cross‐sectional analysis of the PSOCADIA study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Individuals with well‐treated psoriasis exhibited a higher burden of myocardial dysfunction (GLS < 16%) compared with controls, independent of cardiometabolic comorbidity. The prevalence was similar across psoriasis severity, highlighting the importance of cardiovascular assessment in all patients with psoriasis. Abstract Background Psoriasis is linked
Maria Dons, Morten Sengeløv, Kristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Mats C. H. Lassen, Sofie Bøgh‐Sørensen, Filip Soeskov Davidovski, Julie Borchsenius, Peter Schnohr, Gorm Boje Jensen, Rasmus Møgelvang, Christoffer V. Nissen, Peter Riis Hansen, Brittany N. Weber, Claus Zachariae, Lone Skov, Tor Biering‐Sørensen   +16 more
wiley   +1 more source

Cancer co‐medication quality in older patients with polypharmacy: A large randomized trial testing a medication review versus usual care

Journal of Internal Medicine, EarlyView.
Abstract Background Evidence from randomized controlled trials (RCTs) testing medication reviews in geriatric oncology is sparse. Methods We conducted a single‐blinded RCT in ten rehabilitation clinics across Germany. Patients with common cancers, aged ≥ 65 years, and polypharmacy (regularly ≥ five drugs) were randomly allocated in equal proportions to
Miriam Degen, Annette Kopp‐Schneider, Tomislav Vlaski, Sigrid Carlsson, Peter Hallermann, Ludmilla Jewlanowa, Jana Barinoff, Valentin Goede, Christian Lüders, Thomas Kiefer‐Trendelenburg, Diana Lüftner, Jasmin Doll, Jürgen Wagner, Birgit Leibbrand, Hermann Brenner, Ben Schöttker   +15 more
wiley   +1 more source